ArticleRespiratory research2016

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.

Siri T Lehtonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.